[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1980

Effect of Oral Carotenoid Therapy on Erythrocyte Protoporphyrin Levels

Arch Dermatol. 1980;116(8):863-864. doi:10.1001/archderm.1980.01640320013007
Abstract

To the Editor.—  Miao et al1 reported that protoporphyrin levels in erythrocytes of patients with erythropoietic protoporphyria (EPP) were higher in winter than in summer and were elevated during administration of oral beta carotene. In developing a possible explanation for the protective effect of the carotenoid, they cited Piomelli et al2 in support of statements that protoporphyrin leaks from erythrocytes of patients with EPP, and protoporphyrin is rapidly cleared from the plasma in vivo. Since this is not the first time Piomelli et al were cited about in vivo events in EPP,3 a correction is in order. Despite use of the term "in vivo" in the title of the report, the study was an in vitro one. In fact, Scholnick et al4 published information concerning in vivo turnover of plasma protoporphyrin. They administered tritiated δ-aminolevulinic acid (ALA-3H) and glycine labeled with radioactive carbon (glycine

First Page Preview View Large
First page PDF preview
First page PDF preview
×